{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:38:24Z","timestamp":1772775504400,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL110900"],"award-info":[{"award-number":["HL110900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2019.00931","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T13:14:59Z","timestamp":1563974099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Antisickling Drugs Targeting \u03b2Cys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin"],"prefix":"10.3389","volume":"10","author":[{"given":"Tigist","family":"Kassa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Brad","family":"Strader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdu I.","family":"Alayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.05332.x","article-title":"5-Hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells","volume":"128","author":"Abdulmalik","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/rer.2000.5.1.29","article-title":"Hydroxy-urea protects erythrocytes against oxidative damage","volume":"5","author":"Agil","year":"2000","journal-title":"Redox Rep."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bcmd.2017.05.009","article-title":"Oxidative pathways in the sickle cell and beyond","volume":"70","author":"Alayash","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/S0021-9258(18)62234-3","article-title":"Sulfheme proteins. I. Optical and magnetic properties of sulfmyoglobin and its derivatives","volume":"246","author":"Berzofsky","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijbiomac.2016.09.073","article-title":"Sickle cell disease: its molecular mechanism and the one drug that treats it","volume":"93","author":"Ferrone","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1182\/blood-2012-07-441188","article-title":"Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease","volume":"121","author":"George","year":"2013","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1006\/bbrc.2000.3413","article-title":"Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes","volume":"275","author":"Hrinczenko","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1021\/bi011470o","article-title":"Iron nitrosyl hemoglobin formation from the reactions of hemoglobin and hydroxyurea","volume":"41","author":"Huang","year":"2002","journal-title":"Biochemistry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.exphem.2017.02.003","article-title":"Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease","volume":"50","author":"Jagadeeswaran","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"120451","DOI":"10.1172\/jci.insight.120451","article-title":"Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles","volume":"3","author":"Jana","year":"2018","journal-title":"JCI Insight"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1074\/jbc.M609955200","article-title":"Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway","volume":"282","author":"Jia","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"27939","DOI":"10.1074\/jbc.M115.651257","article-title":"Sickle cell hemoglobin in the ferryl state promotes betaCys-93 oxidation and mitochondrial dysfunction in epithelial lung cells (E10)","volume":"290","author":"Kassa","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1039\/C7MT00104E","article-title":"Targeting betaCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects","volume":"9","author":"Kassa","year":"2017","journal-title":"Metallomics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal. Chem."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0304-4165(99)00071-9","article-title":"The reaction of deoxy-sickle cell hemoglobin with hydroxyurea","volume":"1428","author":"Kim-Shapiro","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.freeradbiomed.2004.02.073","article-title":"Nitric oxide production from hydroxyurea","volume":"37","author":"King","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.lab.2005.02.008","article-title":"Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice","volume":"145","author":"Mahaseth","year":"2005","journal-title":"J. Lab. Clin. Med."},{"key":"ref220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ab.2017.01.002","article-title":"Determination of extinction coefficients of human hemoglobin in various redox states","volume":"521","author":"Meng","year":"2017","journal-title":"Anal. Biochem."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1074\/jbc.RA118.006452","article-title":"Substitutions in the beta subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation","volume":"294","author":"Meng","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.3603036","article-title":"Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo","volume":"237","author":"Mozzarelli","year":"1987","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.niox.2018.10.003","article-title":"Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway","volume":"81","author":"Nader","year":"2018","journal-title":"Nitric Oxide"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1021\/acs.molpharmaceut.8b00108","article-title":"A triazole disulfide compound increases the affinity of hemoglobin for oxygen and reduces the sickling of human sickle cells","volume":"15","author":"Nakagawa","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1021\/cb500230b","article-title":"Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling","volume":"9","author":"Nakagawa","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-2143(97)90062-7","article-title":"Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells","volume":"130","author":"Niihara","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1039\/C5OB00367A","article-title":"Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents","volume":"13","author":"Omar","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1021\/pr100252e","article-title":"Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin","volume":"9","author":"Pimenova","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","article-title":"L-glutamine for sickle cell anemia: more questions than answers","volume":"132","author":"Quinn","year":"2018","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"ref32","first-page":"417","article-title":"Review of medication therapy for the prevention of sickle cell crisis","volume":"43","author":"Riley","year":"2018","journal-title":"P T"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1021\/jm0498001","article-title":"Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds","volume":"47","author":"Safo","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/ars.2016.6805","article-title":"Exploring oxidative reactions in hemoglobin variants using mass spectrometry: lessons for engineering oxidatively stable oxygen therapeutics","volume":"26","author":"Strader","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"22342","DOI":"10.1074\/jbc.M114.568980","article-title":"Post-translational transformation of methionine to aspartate is catalyzed by heme iron and driven by peroxide: a novel subunit-specific mechanism in hemoglobin","volume":"289","author":"Strader","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.00931\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:44:53Z","timestamp":1610599493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.00931\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":35,"alternative-id":["10.3389\/fphys.2019.00931"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2019.00931","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]},"article-number":"931"}}